Oversold Stocks — Performance View · Biological Products, (No Diagnostic Substances)
5 stocks match the Oversold Stocks screen. Stocks with an RSI (14) below 30 — technically oversold, most-oversold first. Performance columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–5 of 5
| TCRX | TScan Therapeutics, Inc. | -51.03% | -52.53% | -63.88% | -67.81% | -80.20% | -63.88% | 14.8% | 6.1% | 2.59 | 24K | 0.37 | -5.08% | 61K |
| CRIS | CURIS INC | -10.53% | -69.61% | -84.90% | -92.74% | -95.50% | -92.33% | 2.9% | 11.9% | 0.44 | 5K | 1.36 | -2.16% | 2K |
| SLXN | Silexion Therapeutics Corp | -1.01% | -80.44% | -92.90% | — | — | — | 3.6% | 8.7% | 0.17 | 7K | 0.35 | -0.03% | 1K |
| DYAI | DYADIC INTERNATIONAL INC | -20.61% | -46.88% | -30.27% | -36.91% | -50.03% | -44.99% | 7.4% | 6.6% | 2.63 | 4K | 0.50 | -4.92% | 10K |
| SCLX | Scilex Holding Co | -5.01% | -18.12% | -29.39% | -36.67% | -71.74% | -59.08% | 3.9% | 4.9% | 0.36 | 5K | 5.31 | -0.56% | 2K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.